ILIAS Biologics
Daejeon
About ILIAS Biologics
ILIAS Biologics is a biotechnology company that specializes in therapeutic molecules. The company features platform technology that enables experts to load large therapeutic molecules into exosomes. ILIAS Biologics is developing various therapeutic exosomes, a potential treatment for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $37.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2020)
- Website: iliasbio.comeng
- Phone: (+82) 042.863.4450
Industries & Categories
Biopharma, Biotechnology, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/ilias-biologics-47496 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.